Attached files
| file | filename |
|---|---|
| 10-K/A - Benda Pharmaceutical, Inc. | v185527_10k.htm |
| EX-31 - Benda Pharmaceutical, Inc. | v185527_ex31.htm |
CERTIFICATE
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Yearly Report of Benda Pharmaceutical, Inc. (the "Company")
to Form 10-K for the year ended December 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Yiqing Wan, Chief
Executive Officer and Chief Financial and Accounting Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respect, the financial condition and result of operations of the
Company.
|
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
|
/s/ Yiqing Wan
|
||
|
Name:
|
Yiqing
Wan
|
|
|
Title:
|
Chief
Executive Officer
|
|
|
Chief
Financial and Accounting Officer
|
||
|
Date:
|
May
18, 2010
|
|